PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 77 filers reported holding PROQR THRAPEUTICS N V in Q4 2021. The put-call ratio across all filers is 2.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,299 | -26.1% | 19,461 | -7.9% | 0.00% | – |
| Q2 2023 | $34,223 | -31.3% | 21,126 | -9.6% | 0.00% | – |
| Q1 2023 | $49,791 | -41.4% | 23,377 | +2.2% | 0.00% | – |
| Q4 2022 | $85,000 | +400.0% | 22,876 | +2.2% | 0.00% | – |
| Q3 2022 | $17,000 | 0.0% | 22,376 | +3.5% | 0.00% | – |
| Q2 2022 | $17,000 | -15.0% | 21,626 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -88.2% | 21,626 | +1.7% | 0.00% | – |
| Q4 2021 | $170,000 | -3.4% | 21,265 | +0.9% | 0.00% | – |
| Q3 2021 | $176,000 | +23.9% | 21,065 | 0.0% | 0.00% | – |
| Q2 2021 | $142,000 | +0.7% | 21,065 | -1.1% | 0.00% | – |
| Q1 2021 | $141,000 | – | 21,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |